Tag Archives: 上海夜网HI

17Oct/20

Wolf Administration to Provide Loans to Help Older Pennsylvanians and Those with Disabilities to Live Where They Choose

first_img SHARE Email Facebook Twitter February 04, 2016 Government That Works,  Healthcare,  Human Services,  Seniors Harrisburg, PA – Governor Tom Wolf today announced that the Departments of Human Services (DHS), Aging (PDA), and Community and Economic Development (DCED) are partnering to launch the Home and Community Based Services (HCBS) Loan Program in July 2016.DHS and PDA help seniors and individuals living with disabilities to transition from living in long-term care facilities to residing in the community, ensuring that people have choices about where they live and receive long-term services and supports.“This program will help people to live full, independent lives on their own terms,” said Governor Wolf. “The loans can help build the infrastructure so individuals can live where they want and how they want, giving them many more choices than they would have if living in a facility. I’m thrilled to announce this next step towards accomplishing my administration’s goal to help more Pennsylvanians receive home-based care.”“We believe that supporting the development of a new supports and services structure will mean that more people are served in the right setting,” said DHS Secretary Ted Dallas. “This new system also gives folks the proper amount of support to help them live independently in their homes and communities.”Loans will be provided for projects that help the commonwealth to meet its goal of expanding opportunities for long-term services and supports in the community. It’s expected that loans – for startups, reconfiguration, or expansion — will range from $50,000 to $200,000.DHS’ Office of Long-Term Living (OLTL) will receive loan applications at any time of the year and will process them on a first-come, first-served basis. DCED’s Pennsylvania Economic Development Finance Authority will work with OLTL to process the loans. More information will be supplied in coming months in the Pennsylvania Bulletin.The Pennsylvania Economic Development Financing Authority provides cost-effective financing to businesses by issuing bonds, selling the bonds to private investors, and lending the proceeds to eligible businesses.“The collaborative efforts necessary in order to launch this program is a demonstration of our commitment to Governor Wolf’s government that works initiative for a common goal of creating a better Pennsylvania,” said DCED Secretary Dennis Davin. “DCED is proud to be a part of such an important program.”The loans are intended to support long-term care providers as they position themselves to successfully transition to managed care in Community HealthChoices, Governor Tom Wolf’s plan to improve the quality of care for seniors and individuals living with disabilities through managed long-term services and supports.“The opportunity to best leverage the resources of DHS, DCED, and PDA to launch this program illustrates the Wolf Administration’s commitment to create and sustain a system that allows Pennsylvanians to receive services in the community, preserves consumer choice and actively assists in tapping into the creativity of our provider infrastructure,” said PDA Secretary Teresa Osborne.Like Governor Tom Wolf on Facebook: Facebook.com/GovernorWolfcenter_img Wolf Administration to Provide Loans to Help Older Pennsylvanians and Those with Disabilities to Live Where They Chooselast_img read more

21Sep/20

Hughes prepared for QPR backlash

first_img “I felt we could have turned it around, there were still plenty of games left and good players at the club.” Hughes added: “The impression I get is it (reception) will not be a great one, which is understandable, because since that time a lot has been said, I have not said a great deal about it, I don’t think I need to. “It was a difficult time for everybody. We were all trying to make the club successful, none of us wanted to damage the club, but it did not work for me in that opening part of the season. “QPR fans will remember that time as it was not great for anyone connected with the club, and if they feel they need to vent their frustrations at me, and I will take it on my shoulders. “Fair play, Harry got them back up last year and I wish them well.” Stoke won at Manchester City before the international break, only to then be beaten at home by Leicester. Hughes is expecting a response from both sides. “I watched them last week (at Manchester United) and they will have been disappointed with their performance,” he said. “They will want to bounce back and at home with the support they get from the ground it will be a difficult fixture, but we have enough ability to go there and get a positive result.” Midfielder Marko Arnautovic (foot) and winger Jon Walters (calf) are doubts, but Stephen Ireland should be in contention following a rib muscle injury. After a humiliating 5-0 home defeat by Swansea on the opening day of the 2012/2013 season and a run of 12 league matches without a victory, Hughes was sacked in November 2012 and replaced by Harry Redknapp, who could not keep the club in the top flight, but did secure a swift return after a last-minute victory in the 2014 Sky Bet Championship play-off final at Wembley. Hughes is in little doubt there will be some QPR supporters only too happy to vent their frustrations at him as Redknapp’s side look to put last weekend’s 4-0 defeat at Manchester United out of their system. “It was a difficult period, without a doubt ( the toughest time of my managerial career),” said Hughes, who took over at the Britannia Stadium from Tony Pulis in the summer of 2013 and guided the Potters to ninth place last season. “We made changes that we thought were for the right reasons, would enhance the club and allow the club to be stronger for the future, but sometimes it does not come off and you have to hold your hands up,” “On paper the new players were very good, but the combination and dynamic of the changing room just didn’t work, sometimes you cannot envisage that happening until you bring the group together. “The feeling is maybe too many came in at the same time, but there was always going to be a big turnover. I just wanted to try to increase the quality. “Unfortunately when you don’t win games, and any issues within the group or that they had with me or the staff, then that will manifest itself in poorer performances, which is what happened. “But at the end of the day, we are judged on results and at the beginning of that second season, they were not good enough, so I lost my job, I accept that. Press Association Hughes managed to keep Rangers in the Barclays Premier League after taking over from Neil Warnock in January 2012, albeit by the narrowest of margins on the final day of the campaign as they lost to champions Manchester City in an afternoon of high drama at the Etihad Stadium and Bolton failed to beat Stoke. The Welshman, though, could not build from there, despite a large number of high-profile summer signings. Stoke boss Mark Hughes is ready to meet the QPR boo-boys head on when he goes back to Loftus Road on Saturday for the first time since his sacking 18 months ago. last_img read more

20Jul/19

Potti found guilty of research misconduct

first_imgEight years after questions were first raised about the work of Duke University cancer researcher Anil Potti, federal officials have found Potti guilty of research misconduct. The findings bring to a close one of the most egregious U.S. scientific misconduct cases in recent years.In 2006 Potti’s team published several papers in high-profile journals reporting that certain gene expression signatures predicted a patient’s response to chemotherapy. Two outside biostatisticians soon raised concerns about the studies. In 2010, Duke put Potti on administrative leave and suspended three clinical trials based on his work after The Cancer Letter, a newsletter in Washington, D.C., reported that Potti had padded his resume. Potti resigned a few months later.Many of Potti’s papers were later retracted, and Duke faced a lawsuit filed by patients in the clinical trials. His troubles also led to an Institute of Medicine report that faulted Duke’s oversight and found broad problems in the cancer field with using gene signatures and other biomarkers to guide treatment. Email Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Today, as first reported by the blog Retraction Watch, the federal Office of Research Integrity (ORI) released findings against Potti. Based on Duke’s investigation and ORI’s review, officials concluded that Potti had included false research data in a grant application, a submitted manuscript, and nine research papers. Among other problems, Potti altered data sets to make drug response predictors look more accurate. As part of a voluntary settlement, Potti “neither admits nor denies ORI’s findings of research misconduct.” If he seeks federal funding again, his research must be supervised for 5 years.According to Retraction Watch, Duke Medicine released a statement saying: “We are pleased with the finding of research misconduct. …We trust this will serve to fully absolve the clinicians and researchers who were unwittingly associated with his actions, and bring closure to others who were affected.” The blog notes that as of 3 years ago, Potti was working as an oncologist in North Dakota.center_img Click to view the privacy policy. Required fields are indicated by an asterisk (*) Sign up for our daily newsletter Get more great content like this delivered right to you! Countrylast_img read more